• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Smart Bandage Monitors and Treats Chronic Wounds

      Smart Bandage Monitors and Treats Chronic Wounds

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      CRISPR Combined with Glowing Proteins for Viral Detection

      CRISPR Combined with Glowing Proteins for Viral Detection

    • Radiology
      Imaging Technique Reveals Contraction Patterns During Labor

      Imaging Technique Reveals Contraction Patterns During Labor

      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

      Ultrasound Catheter to Treat Hypertension

      Ultrasound Catheter to Treat Hypertension

      Antibacterial Smart Sutures Visible in CT Scans

      Antibacterial Smart Sutures Visible in CT Scans

    • Cardiology
      Scientists Grow Electrodes Inside The Body

      Scientists Grow Electrodes Inside The Body

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

    • Surgery
      Smart Bandage Monitors and Treats Chronic Wounds

      Smart Bandage Monitors and Treats Chronic Wounds

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

    • Nanomedicine
      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Dermatological Therapeutic Market to Surpass US$ 63,917.4 Mn by 2030 CAGR of 8.0% | Leo Pharma, Pfizer Inc., Novartis AG, Johnson & Johnson

February 6th, 2023 Coherent Market Insights Releases

The industry for dermatological therapeutics has a value of US$37,198.7 million in 2022, and it is anticipated that it would grow by 8.0% between 2023 and 2030 to reach US$63,917.4 million. The higher incidence of dermatological illnesses and the growing geriatric (older) population globally are driving the expansion of the global market for dermatological therapeutics. The market is also anticipated to grow as a result of rising consumer demand for safe and effective therapies and increased public awareness of dermatological illnesses. The global dermatological therapeutic market is anticipated to develop, although growth will be constrained by elements including major adverse effects of some dermatological medications and the discontinuation of clinical trials.

Global Dermatological Therapeutic Market: Regional Insights

On the basis of geography, the global dermatological therapeutic market is divided into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Due to the rising prevalence of skin disorders, rising public awareness, and government campaigns and measures to increase public awareness in this region, North America is predicted to obtain the biggest market share among all other regions over the course of the projection period. For example, the American Academy of Dermatology Association claims that acne, which affects almost 50 million Americans yearly, is the most prevalent skin problem in the country. The number of Americans who have psoriasis exceeds 7.5 million. Consequently, it is anticipated that the demand for dermatological therapies in the area would rise.

Because of the rising incidence of atopic dermatitis and strategic measures done by the government and industry players in this region, Europe is also predicted to experience strong growth in the global dermatological therapeutic market. For instance, according to the European Union’s European Medicines Agency (EMA), up to 7% of people in Europe are thought to have atopic dermatitis, and 30% of adults have the disease’s moderate-to-severe type. As a result, it is anticipated that the need for dermatological therapies in the area would rise, boosting the market for these products worldwide.

Click Here to Get a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/5490

Growing burden of dermatology diseases to boost market growth

The rising prevalence of dermatological illnesses around the world is one of the main reasons anticipated to boost growth of the global market for dermatological therapeutics during the forecast period. With millions of victims worldwide, skin conditions are one of the main contributors to the rising disease burden. Skin conditions impact almost 900 million people worldwide at any given moment, according to the World Health Organization (WHO), making it one of the most prevalent illnesses that influence people’s health. The need for dermatological therapies is growing since skin illnesses are often linked to long-term deformity, disability, and stigma.

Growing geriatric population to underpin the market growth

The rise in the global geriatric (aged) population is another element boosting the global dermatological treatment market. As an illustration, age, as well as environmental and hereditary factors, cause a variety of skin illnesses. Skin conditions may develop more frequently and visibly in elderly persons. Age-related skin conditions are also more likely to develop in persons. The WHO predicts that by 2030, one in six persons worldwide would be 60 years of age or older, and that number will have doubled by 2050. (Around 2.1 billion). The market is being stimulated by this in turn.

Global Dermatological Therapeutic Market Opportunities:

For market participants in dermatological therapeutics, the rising need for safe and efficient dermatological treatments is anticipated to present considerable potential prospects. For instance, the demand for safe and effective therapies is rising at a rapid rate in tandem with the development in the burden of dermatological diseases worldwide. VTAMA (tapinarof), an aryl hydrocarbon receptor agonist, was approved by the U.S. Food and Drug Administration (FDA) in May 2022 for use as a topical therapy for adults with plaque psoriasis. The only steroid-free topical drug in its class that has received FDA approval is this one.

The market for dermatological therapeutics is predicted to have profitable expansion due to the increase in public awareness of dermatological illnesses. Skin conditions, for instance, seriously endanger patients’ physical and mental health as well as their capacity to function and engage in social activities. In order to help patients interact with healthcare providers about the treatment of dermatology diseases and to discuss how the skin diseases are affecting their emotional and mental health, Pfizer, Inc. launched a new programme called “Eczema Inside Out” in collaboration with patient advocacy organisations from various countries.

Global Dermatological Therapeutic Market Trends:

Technological advancements is a recent trend

The ability of market participants to take advantage of market possibilities and hold onto their market position has been made possible by technological developments in dermatology that have received FDA approval. The market will also expand as a result of the discovery of novel therapies or devices to treat dermatological conditions. The market for dermatological therapeutics is anticipated to increase at a faster rate over the forecast period due to the expected continuation of this trend.

Increase in research and development is another trend

To maximise the value of preclinical and clinical stage assets for patients with the dermatological condition, biotech businesses, pharmaceutical companies, universities, and research institutions worldwide are concentrating on establishing partnerships. To better the lives of patients, scientists and medical experts are concentrating on addressing their requirements. The market expansion will likely be fueled by this trend, which is anticipated to last throughout the projected period.

Global Dermatological Therapeutic Market Restraints:

Side effects for certain drugs to hinder growth of the market

The major adverse effects of several dermatological treatments are one of the main reasons anticipated to restrict the expansion of the global market for dermatological therapeutics. Rash, itching, and photosensitivity are typical adverse dermatological reactions. While serious side effects from corticosteroids, anti-acne, anti-infective, retinoids, and other medications are highly noticeable in comparison to others. It’s crucial for the dermatologist to be aware of harmful drug interactions, even though the majority of them don’t show clinical symptoms and may not be seriously worrying.

Termination of the clinical trials to hamper the market growth

The cessation of clinical trials is a further issue preventing the global market for dermatological therapeutics from expanding. As an illustration, in 2019 Galapagos NV and MorphoSys AG terminated their contract with Novartis for the development of the medication MOR106, which was intended for the development for atopic dermatitis. The Phase II trial for MOR106 was unsuccessful, according to Novartis AG. As a result, the market’s expansion is being constrained.

Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/5490

Global Dermatological Therapeutic Market Segmentation:

Application, drug class, and geographic segments are used to segment the worldwide dermatological therapeutic market study.

Based on Application, Atopic Dermatitis, Herpes, Psoriasis, Rosacea, Alopecia, Acne Vulgaris, Vitiligo, Hidradenitis, and Other Applications are the market segments. Because to the rising prevalence of atopic dermatitis, the atopic dermatitis segment is anticipated to dominate the worldwide dermatological therapeutic market over the forecast period. Although it can develop at any age, it is frequently seen in young children.

Acne Vulgaris Segment With acne vulgaris becoming more prevalent, it is also anticipated to experience significant growth in the near future. A frequent skin condition, it can manifest as both inflammatory and non-inflammatory lesions.

Based on Drug Class, the market is divided into categories for retinoids, corticosteroids, calccineurin inhibitors, anti-infectives, and other drug classes. Of these, the Anti-infectives Segment is anticipated to dominate the market over the course of the projected period. This is due to the rise in demand for anti-infectives. Several dermatological conditions are treated with antibiotics.

Corticosteroids Segment since corticosteroids are being used more frequently, it is also anticipated to have significant rise in the near future. The majority of healthcare professionals around the world frequently prescribe these affordable medications.

Global Dermatological Therapeutic Market: Key Developments

In July 2020, The oral janus kinase inhibitor CTP-543 from Concert Pharmaceuticals Inc. has been given new drug designation by the US Food and Drug Administration (FDA) for the treatment of adults with moderate-to-severe alopecia areata.

In March 2020, The U.S. Food and Drug Administration (FDA) designated Baricitinib as a breakthrough medicine for the treatment of alopecia areata, according to an announcement made by Incyte Corporation and Eli Lilly & Company.

In February 2020, Seysara (sarecycline), an oral antibiotic derived from tetracyclines with anti-inflammatory effects for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris, was the subject of a licence agreement between Almirall and Paratek.

In February 2019, The treatment of recurrent herpes simplex (herpes labialis/genital herpes) in Japan has been approved in part by Maruho and Asahi Kasei Pharma’s anti-herpes virus agent “Famvir Tab 250 mg” (famciclovir).

Global Dermatological Therapeutic Market: Key Companies Insights

The market for therapeutic dermatological products is very cutthroat. This is due to an increase in the need for safe and effective therapies; as a result, market participants are concentrating on introducing fresh products to the marketplace.

Top players of the global dermatological therapeutic market are as Bausch Health Companies Inc., AbbVie Inc, XBiotech USA Inc., Almirall, S.A., Amgen Inc., Galderma, GlaxoSmithKline PLC, Johnson & Johnson, Novartis AG, Pfizer Inc., Leo Pharma, and others.

Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/5490

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Dermatological Therapeutic Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Dermatological Therapeutic Industry Impact

Chapter 2 Global Dermatological Therapeutic Competition by Types, Applications, and Top Regions and Countries
2.1 Global Dermatological Therapeutic (Volume and Value) by Type
2.3 Global Dermatological Therapeutic (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Dermatological Therapeutic Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Dermatological Therapeutic Market Analysis
Chapter 6 East Asia Dermatological Therapeutic Market Analysis
Chapter 7 Europe Dermatological Therapeutic Market Analysis
Chapter 8 South Asia Dermatological Therapeutic Market Analysis
Chapter 9 Southeast Asia Dermatological Therapeutic Market Analysis
Chapter 10 Middle East Dermatological Therapeutic Market Analysis
Chapter 11 Africa Dermatological Therapeutic Market Analysis
Chapter 12 Oceania Dermatological Therapeutic Market Analysis
Chapter 13 South America Dermatological Therapeutic Market Analysis
Chapter 14 Company Profiles and Key Figures in Dermatological Therapeutic Business
Chapter 15 Global Dermatological Therapeutic Market Forecast (2023-2030)
Chapter 16 Conclusions
Research Methodology

Read Our More Reports :

Veterinary healthcare market

Cattle healthcare marke

Us compounding pharmacies market

Veterinary vaccines market

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact:

Mr Shah

Coherent Market Insights

533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Sign up and submit a press release

Sponsored
Venture builder BHV Partners launches Conus Airway to improve anaesthesia  and respiratory surgery

Venture builder BHV Partners launches Conus Airway to improve anaesthesia and respiratory surgery

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

interviews & reviews
Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Imagene Profiles Cancer Biomarkers in Real Time

Imagene Profiles Cancer Biomarkers in Real Time

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email